CN111527100A - 肽类抗生素 - Google Patents

肽类抗生素 Download PDF

Info

Publication number
CN111527100A
CN111527100A CN201880084886.9A CN201880084886A CN111527100A CN 111527100 A CN111527100 A CN 111527100A CN 201880084886 A CN201880084886 A CN 201880084886A CN 111527100 A CN111527100 A CN 111527100A
Authority
CN
China
Prior art keywords
dab
compound
leu
substituted
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201880084886.9A
Other languages
English (en)
Chinese (zh)
Inventor
M·库伯
M·布拉斯科维奇
A·加拉尔多戈多伊
K·汉斯福德
A·埃利奥特
B·贝克尔
C·马尔登
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Queensland UQ
Original Assignee
University of Queensland UQ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2017904465A external-priority patent/AU2017904465A0/en
Application filed by University of Queensland UQ filed Critical University of Queensland UQ
Publication of CN111527100A publication Critical patent/CN111527100A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • C07K7/62—Polymyxins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
CN201880084886.9A 2017-11-02 2018-11-02 肽类抗生素 Pending CN111527100A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2017904465A AU2017904465A0 (en) 2017-11-02 Peptide antibiotics
AU2017904465 2017-11-02
PCT/AU2018/051194 WO2019084628A1 (en) 2017-11-02 2018-11-02 Peptide antibiotics

Publications (1)

Publication Number Publication Date
CN111527100A true CN111527100A (zh) 2020-08-11

Family

ID=66331139

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201880084886.9A Pending CN111527100A (zh) 2017-11-02 2018-11-02 肽类抗生素

Country Status (6)

Country Link
US (1) US11279733B2 (https=)
EP (1) EP3704135A4 (https=)
JP (1) JP2021501783A (https=)
CN (1) CN111527100A (https=)
AU (1) AU2018359018B2 (https=)
WO (1) WO2019084628A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021247978A1 (en) * 2020-06-05 2021-12-09 The Rockefeller University Antibacterial synthetic-bioinformatic natural products and uses thereof
US20250346633A1 (en) * 2021-04-27 2025-11-13 The Rockefeller University Macolacins and methods of use thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002055543A2 (en) * 2001-01-16 2002-07-18 Univ Ramot Hybrid peptides for treatment of bacteremia and septicemia
WO2016083531A1 (en) * 2014-11-26 2016-06-02 New Pharma Licence Holdings Limited Compounds

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3880994A (en) 1972-12-06 1975-04-29 Bristol Myers Co Antibiotic BU-1880
JPS5025795A (https=) 1973-07-10 1975-03-18
US4341768A (en) * 1981-04-03 1982-07-27 Bristol-Myers Company Antibiotic compounds
GB2128617A (en) * 1982-10-06 1984-05-02 Martti Vaara Polypeptides for use in antibacterial therapy
CA2047033A1 (en) * 1990-07-19 1992-01-20 Elizabeth E. Sugg Cyclic hiv principal neutralizing determinant peptides
US20060004185A1 (en) * 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
BRPI0715095B8 (pt) * 2006-08-11 2021-05-25 Northern Antibiotics Oy derivado de polimixina da fórmula geral (i); produto de combinação; composição farmacêutica; método para se sensibilizar bactérias gram-negativas a um agente antibacteriano; método para o desenvolvimento de antibióticos; método para a redução da toxicidade de polimixinas, octapeptinas naturais e seus derivados durante a aplicação das mesmas no tratamento de infecções em um indivíduo; método para melhorar as propriedades farmacocinéticas, de polimixinas, octapeptinas naturais e seus derivados; método para a sensibilização de bactérias gram-negativas clinicamente importantes a um complemento de mecanismo de defesa presente no soro; uso de um derivado; e processo para a preparação de um derivado de polimixina da fórmula (i).
US9096649B2 (en) * 2008-02-08 2015-08-04 Northern Antibiotics Ltd. Polymyxin derivatives and uses thereof
FI20085469A0 (fi) * 2008-02-08 2008-05-16 Northern Antibiotics Oy Polymyksiinijohdannaiset, joissa on lyhyt rasvahappohäntä, ja niiden käyttöjä
WO2010130007A1 (en) 2009-05-14 2010-11-18 Monash University Antimicrobial compounds
ES2374779B1 (es) 2010-03-10 2012-12-27 Universidad De Barcelona Compuestos péptidicos útiles como agentes antibacterianos.
WO2012168820A1 (en) 2011-06-08 2012-12-13 Pfizer Inc. Polymyxin derivatives useful as antibacterial agents
CA2855916A1 (en) * 2011-11-18 2013-05-23 Novacta Biosystems Limited Polymyxin derivatives
KR102354902B1 (ko) 2013-05-22 2022-01-24 에버레스트 메디신즈 (싱가포르) 피티이. 리미티드 폴리믹신 유도체 및 상이한 항생제와의 조합 요법에 있어서의 이들의 용도
MX359104B (es) 2014-03-11 2018-09-14 New Pharma Licence Holdings Ltd Derivados de polimixina y su uso en terapia de combinacion junto con diferentes antibioticos.
JP2017512818A (ja) * 2014-04-01 2017-05-25 モナシュ、ユニバーシティＭｏｎａｓｈ Ｕｎｉｖｅｒｓｉｔｙ 抗菌性化合物としてのポリミキシン誘導体
WO2016100578A2 (en) 2014-12-16 2016-06-23 Micurx Pharmaceuticals, Inc. Antimicrobial polymyxins for treatment of bacterial infections
EP3274361A1 (en) 2015-03-23 2018-01-31 Polyphor Ag Beta-hairpin peptidomimetics
EP3356387B1 (en) 2015-09-29 2024-06-26 Monash University Antimicrobial polymyxin derivative compounds
WO2017189868A1 (en) * 2016-04-27 2017-11-02 Spero Opco Serine replacement polymyxin analogues useful as antibiotic potentiators

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002055543A2 (en) * 2001-01-16 2002-07-18 Univ Ramot Hybrid peptides for treatment of bacteremia and septicemia
WO2016083531A1 (en) * 2014-11-26 2016-06-02 New Pharma Licence Holdings Limited Compounds

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ALEJANDRA GALLARDO-GODOY等: "Activity and Predicted Nephrotoxicity of Synthetic Antibiotics Based on Polymyxin B", 《J. MED. CHEM.》 *
BERND BECKER等: "Synthesis of octapeptin C4 and biological profiling against NDM-1 and polymyxin-resistant bacteria", 《BIOORGANIC & MEDICINAL CHEMISTRY LETTERS》 *
MEI-LING HAN等: "Investigating the Interaction of Octapeptin A3 with Model Bacterial Membranes", 《ACS INFECT.》 *
WILLIAM L. PARKER等: "EM49, A NEW PEPTIDE ANTIBIOTIC II. CHEMICAL CHARACTERIZATION", 《THE JOURNAL OF ANTIBIOTICS》 *

Also Published As

Publication number Publication date
JP2021501783A (ja) 2021-01-21
EP3704135A4 (en) 2022-04-27
AU2018359018A1 (en) 2020-05-14
US20200361994A1 (en) 2020-11-19
EP3704135A1 (en) 2020-09-09
WO2019084628A1 (en) 2019-05-09
US11279733B2 (en) 2022-03-22
AU2018359018B2 (en) 2022-11-24

Similar Documents

Publication Publication Date Title
JP7117021B2 (ja) 抗菌性化合物としてのポリミキシン誘導体
EP2331501B1 (en) Small molecule inhibitors of n-terminus activation of the androgen receptor
CN114051496B (zh) 将联苯基引入新型氨基烷酸的衍生物化合物及包含其的抗真菌药学组合物
US20250074945A1 (en) Antibacterial cyclopeptides targeting acinetobacter and other gram-negative pathogens
CN111527100A (zh) 肽类抗生素
JP5430559B2 (ja) 新規ぺプチドデホルミラーゼ阻害化合物とその製造方法
KR20180024002A (ko) 신규한 바이사이클릭 리포란티펩티드, 제조 및 항균제로서의 용도
DK2473480T3 (en) Novel antibacterial hydroxyphenylforbindelse
EP1807443A1 (de) Acylierte nonadepsipeptide als lysobactinderivate
WO2024043249A1 (ja) 環状ペプチドまたはその塩、およびｍｄｍｘ阻害剤
JP5689892B2 (ja) ２−アミノ−３−メチル−ヘキサ−５エン酸、及びバシトラシン等のペプチドの生成におけるその使用方法
AU2021105736A4 (en) Synthesis, characterization and biological evaluation of Cyclo-octapeptide, Cyclogossine B (77)
Dahiya et al. Synthetic and pharmacological studies on a natural cyclopeptide from Gypsophila arabica
TW202530242A (zh) 胜肽
TW202417465A (zh) 環肽或其鹽及ｍｄｍｘ抑制劑
Dakada THE MEDICINAL CHEMISTRY OF SELECTED HALOGENATED DIKETOPIPERAZINES CYCLO (CIS-PRO-4F-PRO) AND CYCLO (L-PHE-4I-VAL)
TW202547853A (zh) 親環蛋白抑制劑及其用途
HK40060177B (zh) 将联苯基引入新型氨基烷酸的衍生物化合物及包含其的抗真菌药学组合物
HK1153198B (en) Small molecule inhibitors of n-terminus activation of the androgen receptor
WO2012101388A1 (fr) Nouveaux derives d'azacoumarines presentant une activite inhibitrice des pompes mdr
WO2020079001A1 (en) Compounds for use in the treatment of bacterial infections
Li Explore the Multivalency and Self-Assembly of Small Molecules for Potential Therapeutic Applications
GB2522412A (en) Antimicrobial peptidomimetics
PL226349B1 (pl) Pentapeptydy zawierające 3-[2-(2-chinolilo)benzoksazol-5-ylo] alaninę, kompozycja farmaceutyczna oraz ich zastosowanie
AU2012201797A1 (en) New hybrid oligomers, their preparation process and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20200811

WD01 Invention patent application deemed withdrawn after publication